Invention Grant
US08524463B2 Diagnosis and risk classification of acute coronary syndrome by means of CT-proET-1 in combination with NT-proBNP
有权
通过CT-proET-1与NT-proBNP联合治疗急性冠状动脉综合征的诊断和风险分类
- Patent Title: Diagnosis and risk classification of acute coronary syndrome by means of CT-proET-1 in combination with NT-proBNP
- Patent Title (中): 通过CT-proET-1与NT-proBNP联合治疗急性冠状动脉综合征的诊断和风险分类
-
Application No.: US12520166Application Date: 2007-12-22
-
Publication No.: US08524463B2Publication Date: 2013-09-03
- Inventor: Andreas Bergmann , Nils Morgenthaler , Jana Papassotiriou , Joachim Struck , Leong L. Ng
- Applicant: Andreas Bergmann , Nils Morgenthaler , Jana Papassotiriou , Joachim Struck , Leong L. Ng
- Applicant Address: DE Henningsdorf
- Assignee: B.R.A.H.M.S GmbH
- Current Assignee: B.R.A.H.M.S GmbH
- Current Assignee Address: DE Henningsdorf
- Agency: Novak Druce Connoly Bove + Quigg LLP
- Priority: DE102006060835 20061222
- International Application: PCT/DE2007/002313 WO 20071222
- International Announcement: WO2008/077396 WO 20080703
- Main IPC: G01N31/00
- IPC: G01N31/00 ; G01N33/53
Abstract:
The invention relates to a method for diagnosis and/or risk classification for acute coronary syndrome (ACS), in particular for acute myocardial infarct (AMI) and angina pectoris (AP) and/or a post-myocardial infarct, wherein a determination of the C-terminal pro-endothelin (CT-proET-1) or fragments and partial peptides therefrom, is carried out in combination with NT-proBNP.
Public/Granted literature
Information query
